Anticataracticum [Supplementary Concept]

solution contains inosine monophsphate, nicotinamide, disodium succinate, magnesium L-aspartate, & chlorhexidine gluconate; tablet contains uridine-5-monophosphate & magnesium L-aspartate; RN given is for solution

Date introduced: April 29, 1991

MeSH Unique ID: C068080

Registry Number: 138240-73-0

Heading Mapped to:

• Aspartic Acid
• Drug Combinations
• Inosine Monophosphate
• Niacinamide